SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer’s disease

Authors

Carlos Cruchaga, Washington University School of Medicine in St. Louis
John S. K. Kauwe, Brigham Young University - Utah
Kevin Mayo, Washington University School of Medicine in St. Louis
Noah Spiegel, Washington University School of Medicine in St. Louis
Sarah Bertelsen, Washington University School of Medicine in St. LouisFollow
Petra Nowotny, Washington University School of Medicine in St. Louis
Aarti R. Shah, Washington University School of Medicine in St. Louis
Richard Abraham, University of Washington - Seattle Campus
Paul Holligworth, Cardiff University
Denise Harold, Cardiff University
Michael M. Owen, Cardiff University
Julie Williams, Cardiff University
Simon Lovestone, Kings College, London, United Kingdom
Elaine R. Peskind, University of Washington - Seattle Campus
Ge Li, University of Washington - Seattle Campus
James B. Leverenz, University of Washington - Seattle CampusFollow
Douglas Galasko, University of California - San Diego
The Alzheimer's Disease Neuroimaging Initiative, Washington University School of Medicine in St. Louis
John C. Morris, Washington University School of Medicine in St. Louis
Anne M. Fagan, Washington University School of Medicine in St. LouisFollow
David M. Holtzman, Washington University School of Medicine in St. LouisFollow
Alison M. Goate, Washington University School of Medicine in St. LouisFollow

Journal

PLoS Genetics

Publication Date

2010

Volume

6

Issue

9

Inclusive Pages

e1001101

Document Type

Open Access Publication

DOI

10.1371/journal.pgen.1001101

Rights and Permissions

Cruchaga C, Kauwe JSK, Mayo K, Spiegel N, Bertelsen S, et al. 2010 SNPs Associated with Cerebrospinal Fluid Phospho-Tau Levels Influence Rate of Decline in Alzheimer's Disease. PLoS Genet 6(9): e1001101. doi:10.1371/journal.pgen.1001101

Recommended Citation

Cruchaga, Carlos; K. Kauwe, John S.; Mayo, Kevin; Spiegel, Noah; Bertelsen, Sarah; Nowotny, Petra; Shah, Aarti R.; Abraham, Richard; Holligworth, Paul; Harold, Denise; Owen, Michael M.; Williams, Julie; Lovestone, Simon; Peskind, Elaine R.; Li, Ge; Leverenz, James B.; Galasko, Douglas; The Alzheimer's Disease Neuroimaging Initiative; Morris, John C.; Fagan, Anne M.; Holtzman, David M.; and Goate, Alison M., "SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer’s disease." PLoS Genetics. 6, 9. e1001101. (2010).
https://digitalcommons.wustl.edu/open_access_pubs/706